Patent ID: 9452142
Filing Date: 2016-09-27
CPC Classification: A61K,A61P

Claim Text:
1. An oral dosage form for administration to an animal comprising a biologically utilizable form of calcium and a continuous release system for releasing said biologically utilizable form of calcium over an extended period of time after administration of said dosage form to said animal, wherein the formulation consisting essentially of 1,322.3 mg of Calcium Carbonate; 437.9 mg of Calcium Citrate; 110.4 mg of Magnesium Hydroxide; 67.5 mg of Hypromellose: 40.6 mg of Croscarmellose Sodium; 6.5 mg of Magnesium Silicate; 4.3 mg of Titanium Dioxide; 4.3 mg of Propylene Glycol/Dicaprylate/Dicaprate; 1.25 mg of Magnesium Sterate; 1.1 mg of Oligofructose Enriched Inulin; and 0.018 mg of Vitamin D3; and wherein the oral dosage form is adapted to maintain a steady state calcium level in the plasma of the animal by the continuous release of calcium from the administered dosage form for 24 hours.